CLINICAL TRIALS PROFILE FOR ESCITALOPRAM OXALATE
✉ Email this page to a colleague
All Clinical Trials for Escitalopram Oxalate
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00149825 ↗ | Combining Antidepressant Medication and Psychotherapy for Insomnia to Improve Depression Outcome | Completed | National Institute of Mental Health (NIMH) | Phase 2 | 2004-06-01 | This study will examine the effectiveness of a combination of antidepressant medication and sleep-focused psychotherapy to simultaneously treat sleep difficulties and depression. |
| NCT00149825 ↗ | Combining Antidepressant Medication and Psychotherapy for Insomnia to Improve Depression Outcome | Completed | Stanford University | Phase 2 | 2004-06-01 | This study will examine the effectiveness of a combination of antidepressant medication and sleep-focused psychotherapy to simultaneously treat sleep difficulties and depression. |
| NCT00222820 ↗ | Depression: The Search for Treatment-Relevant Phenotypes-Pilot Study | Completed | Mental Health Intervention Research Center (MHIRC) | Phase 4 | 2002-04-01 | We are doing this pilot study to learn more about four aspects of treating depression: 1. The features of a depressed person's mood and anxiety and how these features affect a person's capacity to get better and stay better. 2. If depressed people with certain features of mood and anxiety respond better to therapy, medication or a combination of therapy and medication. 3. Whether or not a person's personality traits affect how they respond to treatment. 4. The gene involved in processing antidepressant medication |
| NCT00222820 ↗ | Depression: The Search for Treatment-Relevant Phenotypes-Pilot Study | Completed | University of Pittsburgh | Phase 4 | 2002-04-01 | We are doing this pilot study to learn more about four aspects of treating depression: 1. The features of a depressed person's mood and anxiety and how these features affect a person's capacity to get better and stay better. 2. If depressed people with certain features of mood and anxiety respond better to therapy, medication or a combination of therapy and medication. 3. Whether or not a person's personality traits affect how they respond to treatment. 4. The gene involved in processing antidepressant medication |
| NCT00235508 ↗ | Safety and Efficacy of Eszopiclone in Patients With Generalized Anxiety Disorder | Completed | Sunovion | Phase 4 | 2005-06-01 | To determine the safety and efficacy of eszopiclone as adjunctive therapy in the treatment of insomnia in patients with insomnia related to Generalized Anxiety Disorder. All subjects will receive an approved anxiolytic agent and will be randomized to nightly therapy with either eszopiclone or placebo. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Escitalopram Oxalate
Condition Name
Clinical Trial Locations for Escitalopram Oxalate
Trials by Country
Clinical Trial Progress for Escitalopram Oxalate
Clinical Trial Phase
Clinical Trial Sponsors for Escitalopram Oxalate
Sponsor Name
